Nagano et al. have developed a score for differentiating lipoma from ALT that includes the diameter of the lesion, the depth of the location, the presence of intratumoral septa, and the post-contrast substance administration accentuation examined by MRI. The gene discussed is GPT; the disease is lipoma.